Propeller Health

By Joe Slavinsky May 16, 2019
About the author: Joe Slavinsky leads business development efforts with pharmaceutical, biotechnology and medical technology companies in his VP position at Propeller Health. A former epidemiologist, he worked at a hedge fund (Citadel) and an investment bank (Thomas Weisel Partners) as an equity research analyst covering small/mid-cap biotechnology companies. Joe joined Propeller from Gilead...
By Dave Muoio February 12, 2019
Propeller Health’s digital respiratory health platform will be making a bigger splash among European patients thanks to a partnership announced yesterday with Finnish pharmaceuticals and diagnostics company Orion Corporation. Starting in 2019, the companies will begin co-development of a custom-built Propeller sensor for Orion’s Easyhaler line of inhaled pulmonary drugs. These new sensors will...
By Jonah Comstock January 10, 2019
Respiratory health company Propeller Health, which was recently acquired by ResMed for $225 million, announced this week in San Francisco a partnership with Walgreens and a new feature for users of its platform. The new feature, called My Pharmacy, will allow Propeller’s end users, patients with asthma and COPD, to connect to pharmacy services without leaving the Propeller app. At launch, users...
By Laura Lovett December 3, 2018
This morning ResMed, maker of connected respiratory devices, announced that it is acquiring Wisconsin-based digital respiratory health company Propeller Health for $225 million.  ResMed, a publicly traded company, is set to finalize the acquisition of Propeller Health by March 2019, which marks the end of its 2019 fiscal year.  Propeller is best known for its smart inhalers that help people...
By Dave Muoio August 21, 2018
Anthem Blue Cross and Blue Shield in Ohio has partnered with Propeller Health to provide sensor-equipped inhaler attachments to plan members with COPD. The rollout will give members access to Propeller’s medication tracker app, while providing an online provider portal for the insurer’s care management team. “There’s currently no cure for COPD, but much can be done to help consumers treat the...
Easing pain with virtual reality
By Babyforyou.net.ua June 11, 2018
The latest digital health news briefs for June 11. Easing pain with VR in Paris Healthy Mind, a French startup using virtual reality headsets to curb pain in emergency rooms, is being used at Saint-Joseph Hospital in Paris, according to a Reuters report. The startup has landed a $20,000 prize from The University of Adelaide in Australia and has plans to present the technology to Microsoft in...
By Dave Muoio June 7, 2018
Deep breaths. Henry Schein Medical announced today the launch of its EasyOne Air Spirometer, a device designed to measure lung function and improve diagnosis of COPD. Connected via Bluetooth, the spirometer includes a touch screen interface, EHR connectivity, and proprietary technology to improve device calibration and accuracy. "We are excited to work with ndd [the device’s designer] to provide...
By Dave Muoio May 30, 2018
Today, Madison, Wisconsin-based digital respiratory health company Propeller Health announced a $20 million funding round led by a $10 million investment from Aptar Pharma. Existing investors Safeguard Scientifics, Social Capital, Hikma Ventures, 3M Ventures, and SR One comprised the other half of the round. According to a release, the new funding will be invested into the company’s digital...
By Dave Muoio April 3, 2018
A partnership between Louisville, Kentucky city leaders, a non-profit, and digital respiratory health company Propeller Health has led to clear improvements in local asthmatic residents’ inhaler use and symptoms, according to a study recently published in Health Affairs.  Furthermore, data collected and made available through the digital respiratory health company’s crowdsourced platform offered...
By Jonah Comstock March 12, 2018
Digital therapeutics may be up and coming, but they also have a long way to go before their mainstream treatment options, according to experts who spoke at the digital therapeutics deep dive at HIMSS18. “This is going to be a completely new industry sector,” Pierre Leurent, CEO of Voluntis, said during the session. “It’s going to have very strong growth in the years to come and it’s going to be a...
www.steroid-pharm.com

www.steroid-pharm.com

Tadalafil sans ordonnance